Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nelson Chao

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
Induction of Wilms' tumor protein (WT1)-specific antitumor immunity using a truncated WT1-expressing adenovirus vaccineTakuya Osada, Christopher Y Woo, Matthew McKinney, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2010
Renal shielding and dosimetry for patients with severe systemic sclerosis receiving immunoablation with total body irradiation in the scleroderma: cyclophosphamide or transplantation trialOana I Craciunescu, Beverly A Steffey, Chris R Kelsey, et al.
Blood|December 11, 2012
Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemiaAndromachi Scaradavou, Claudio G Brunstein, Mary Eapen, et al.
Blood|February 21, 2008
Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging studyDrew J Winston, Jo-Anne H Young, Vinod Pullarkat, et al.
Journal of Hematology & Oncology|August 19, 2016
Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recoveryMichael M B Green, Nelson Chao, Saurabh Chhabra, et al.
Bone Marrow Transplantation|October 20, 2021
Cognitive impairment in candidates for allogeneic hematopoietic stem cell transplantationPatrick J Smith, Meagan Lew, Yen Lowder, et al.
Blood Cancer Journal|May 17, 2021
Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplantCindy M Pabon, Zhiguo Li, Therese Hennig, et al.
Transplantation and Cellular Therapy|May 15, 2021
Decreased Mortality in 1-Year Survivors of Umbilical Cord Blood Transplant vs. Matched Related or Matched Unrelated Donor Transplant in Patients with Hematologic MalignanciesLauren Bohannon, Helen Tang, Kristin Page, et al.
The Lancet. Oncology|June 19, 2010
Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysisMary Eapen, Vanderson Rocha, Guillermo Sanz, et al.
Global Health, Science and Practice|December 28, 2020
Capturing Acquired Wisdom, Enabling Healthful Aging, and Building Multinational Partnerships Through Senior Global Health MentorshipC Norman Coleman, John E Wong, Eugenia Wendling, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
Induction of Wilms' tumor protein (WT1)-specific antitumor immunity using a truncated WT1-expressing adenovirus vaccineTakuya Osada, Christopher Y Woo, Matthew McKinney, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2010
Renal shielding and dosimetry for patients with severe systemic sclerosis receiving immunoablation with total body irradiation in the scleroderma: cyclophosphamide or transplantation trialOana I Craciunescu, Beverly A Steffey, Chris R Kelsey, et al.
Blood|December 11, 2012
Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemiaAndromachi Scaradavou, Claudio G Brunstein, Mary Eapen, et al.
Blood|February 21, 2008
Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging studyDrew J Winston, Jo-Anne H Young, Vinod Pullarkat, et al.
Journal of Hematology & Oncology|August 19, 2016
Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recoveryMichael M B Green, Nelson Chao, Saurabh Chhabra, et al.
Bone Marrow Transplantation|October 20, 2021
Cognitive impairment in candidates for allogeneic hematopoietic stem cell transplantationPatrick J Smith, Meagan Lew, Yen Lowder, et al.
Blood Cancer Journal|May 17, 2021
Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplantCindy M Pabon, Zhiguo Li, Therese Hennig, et al.
Transplantation and Cellular Therapy|May 15, 2021
Decreased Mortality in 1-Year Survivors of Umbilical Cord Blood Transplant vs. Matched Related or Matched Unrelated Donor Transplant in Patients with Hematologic MalignanciesLauren Bohannon, Helen Tang, Kristin Page, et al.
The Lancet. Oncology|June 19, 2010
Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysisMary Eapen, Vanderson Rocha, Guillermo Sanz, et al.
Global Health, Science and Practice|December 28, 2020
Capturing Acquired Wisdom, Enabling Healthful Aging, and Building Multinational Partnerships Through Senior Global Health MentorshipC Norman Coleman, John E Wong, Eugenia Wendling, et al.
Pageof 10